| Financial Year |
March 31 2023 |
| Monetary Funds |
2,258,386,163.15 |
| Held-for-trading Financial Assets |
666,096,682.19 |
| Notes Receivable |
10,789,930.56 |
| Accounts Receivable |
1,400,704,188.08 |
| Advances to Suppliers |
99,150,214.24 |
| Other Receivables |
75,002,532.90 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
772,107,105.86 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,066,089.96 |
| Total Current Assets |
5,354,408,717.68 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
753,553,814.65 |
| Under-construction Projects |
431,842,003.71 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
185,144,737.41 |
| R&D expenses |
-- |
| Goodwill |
39,500.71 |
| Long-Term Deferred and Prepaid Expenses |
281,842.16 |
| Deferred Income Tax Assets |
16,211,954.47 |
| Other Non-Current Assets |
13,257,080.78 |
| Sub-Total of Non-Current Assets |
1,687,906,726.71 |
| Total Assets |
7,042,315,444.39 |
| Short-Term Loans |
718,834,085.13 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,056,817,080.92 |
| Accounts Payable |
1,455,570,067.50 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
99,626,792.82 |
| Taxes Payable |
102,253,846.20 |
| Interest Payable |
-- |
| Dividend Payable |
11,531,370.98 |
| Other payables |
185,770,469.82 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
38,818,739.47 |
| Other Current Liabilities |
9,787,256.53 |
| Sub-Total of Current Liabilities |
4,850,653,496.60 |
| Long-term Loans |
45,581,250.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
15,771,468.15 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
100,308,848.94 |
| Total Liabilities |
4,950,962,345.54 |
| Paid-In Capital(Or Share Stock) |
1,084,111,428.00 |
| Capital Surplus |
1,655,928,255.34 |
| Surplus Reserve |
119,716,312.07 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,608,917,006.17 |
| Minority Stockholder's Interest |
1,098,308,415.32 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
993,044,683.53 |
| Owner's Equity（Stockholder's Equity） |
2,091,353,098.85 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,042,315,444.39 |
